FamiCord signs manufacturing deal with Verigraft worth low single-digit millions of euros
Bitget2026/09/24 10:28- FamiCord signed a manufacturing agreement with Verigraft to support a pivotal Phase II/III trial for its P-TEV vein graft.
- Work covers process transfer, GMP manufacturing setup in Warsaw, tissue sourcing support; contract runs about 18 months.
- Estimated initial contract value sits in the low single-digit millions of euros, tied to trial progress and manufacturing demand.
- Phase II/III trial TECVI-2 is expected to start in Q1 2027, with sites planned in Spain, Poland, the Netherlands.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Lithium-For-Earth Raises KRW 1.32 Billion in Private Placement
Anthropic "accidentally" leaks IPO documents! Plans to raise $69.3 billion, valuation drops from 2 trillion to 1.3 trillion
Anthropic mistakenly published and then withdrew a prospectus for a planned $69.3 billion fundraising, with its valuation dropping from a peak of $2 trillion to between $1.1 trillion and $1.3 trillion.
Subaru Publishes Transcript of First-Half FYE 2027 Financial Results Presentation
Citi: Occidental Petroleum (OXY.US) Q3 cash flow surpasses expectations, accelerated debt repayment cannot hide concerns over Q4 output
Citi published a research report maintaining Occidental Petroleum's "Neutral" rating, with a target price of $65.
Crypto prices
More
